Does spironolactone have a dose-dependent effect on left ventricular remodeling in patients with preserved left ventricular function after an acute myocardial infarction?

Cardiovascular Therapeutics

Volumn 31, Issue 4, 2013, Pages 224-229

  Vatankulu, Mehmet Akif ^a   Bacaksiz, Ahmet ^a   Sonmez, Osman ^a   Alihanoglu, Yusuf ^b   Koc, Fatih ^c   Demir, Kenan ^d   Gul, Enes Elvin ^d   Turfan, Murat ^a   Tasal, Abdurrahman ^a   Kayrak, Mehmet ^d   Yazici, Mehmet ^d   Ozdemir, Kurtulus ^d  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

^c GAZIOSMANPASA UNIVERSITY   (Turkey)

^d SELCUK UNIVERSITY   (Turkey)

Author keywords

Aldosterone; Myocardial infarction; Preserved ejection fraction; Remodeling; Spironolactone

Indexed keywords

ACETYLSALICYLIC ACID; BISOPROLOL; CARVEDILOL; FOSINOPRIL; METOPROLOL; PERINDOPRIL; RAMIPRIL; SPIRONOLACTONE; VALSARTAN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GYNECOMASTIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEART VENTRICLE REMODELING; HUMAN; HYPERKALEMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ALDOSTERONE; MYOCARDIAL INFARCTION; PRESERVED EJECTION FRACTION; REMODELING; SPIRONOLACTONE;

ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SPIRONOLACTONE; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; TURKEY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84880666917     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12006     Document Type: Article

References (15)

1. Køber L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670-1676.
2. Pitt B, Fonarow GC, Gheorghiade M, Deedwania PC, Duprez DA. Improving outcomes in post-acute myocardial infarction heart failure: Incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade. Am J Cardiol 2006;97(suppl):26F-33F.
3. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321.
4. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction- executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:588-636.
5. Hayashi M, Tsutamoto T, Wada A, et al. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 2003;107:2559-2565.
6. Savoye C, Equine O, Tricot O, et al. Left ventricular remodelling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntricularie[REVE] study group). Am J Cardiol 2006;98:1144-1149.
7. American Heart Association. Heart disease and stroke statistics-2005 update. Dallas, TX: American Heart Association, 2005.
8. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
9. Vizzardi E, D'Aloia A, Giubbini R, et al. Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure. Am J Cardiol 2010;106:1292-1296.
10. Udelson JE, Feldman AM, Greenberg B, Pitt B, Mukherjee R, Solomon HA, Konstam MA. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction. Circ Heart Fail 2010;3:347-353.
11. Weir RA, Mark PB, Petrie CJ, et al. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect? Am Heart J 2009;157:1088-1096.
12. Temporelli PL, Giannuzzi P, Nicolosi GL, et al. Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo substudy. J Am Coll Cardiol 2004;43:1646-1653.
13. Cerisano G, Bolognese L, Carrabba N, et al. Doppler-derived mitral deceleration time: an early strong predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction. Circulation 1999;99:230-236.
14. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004;109:1121-1126.
15. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM, Antoniucci D. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106:2351-2357.